Target intelligence / Profile preview

RNA processing and function

Molecular classification
Other
01

Overview

RNA processing and function encompass the essential cellular pathways that transform primary RNA transcripts into mature, functional molecules. These processes include 5' capping, pre-mRNA splicing, 3' polyadenylation, and RNA editing, which collectively ensure the fidelity and diversity of the proteome (Alberts et al., 2002). Dysregulation of RNA processing is a hallmark of various pathologies, including cancer, where aberrant splicing can generate oncogenic isoforms, and neurodegenerative diseases like spinal muscular atrophy (SMA) (Scotti & Swanson, 2016). Therapeutic strategies targeting these pathways have evolved rapidly, utilizing antisense oligonucleotides (ASOs) and small molecule splicing modifiers to correct genetic defects or modulate protein expression (Crooke et al., 2021). For instance, drugs like Nusinersen and Risdiplam target the SMN2 gene's splicing to treat SMA by increasing the production of functional SMN protein (Ratni et al., 2018). Other approaches include exon skipping for Duchenne muscular dystrophy, where ASOs like Eteplirsen restore the reading frame of the dystrophin gene (Lim et al., 2017). While these interventions offer transformative potential, they face challenges such as achieving tissue-specific delivery and minimizing off-target effects on the broader transcriptome.

Other names
RNA metabolismPost-transcriptional processingRNA maturationRNA modification
02

Mechanism of action

Modulation of pre-mRNA splicing, exon skipping, exon inclusion, and RNA interference to restore or alter protein expression (Crooke et al., 2021).

03

Biological functions

RNA splicingRNA cappingPolyadenylationRNA transportRNA editingRNA degradationTranslation regulation
04

Disease associations

CancerNeurodegenerative diseaseSpinal muscular atrophyDuchenne muscular dystrophyAmyotrophic lateral sclerosisMyotonic dystrophy
05

Safety considerations

Off-target splicing effectsRenal toxicityThrombocytopeniaInjection site reactionsImmunogenicity of antisense oligonucleotides
06

Interacting drugs

Nusinersen

6 more in the full profile.

07

Biomarkers

mRNA isoform expression levelsSMN protein levelsDystrophin protein expressionRNA-binding protein (RBP) activity

Beyond the preview

Go deeper on RNA processing and function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA processing and function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call